BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16014636)

  • 1. Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN.
    Agrawal S; Pilarski R; Eng C
    Hum Mol Genet; 2005 Aug; 14(16):2459-68. PubMed ID: 16014636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
    Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
    Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of splicing defects in PTEN leading to exon skipping or partial intron retention in Cowden syndrome.
    Celebi JT; Wanner M; Ping XL; Zhang H; Peacocke M
    Hum Genet; 2000 Sep; 107(3):234-8. PubMed ID: 11071384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN: one gene, many syndromes.
    Eng C
    Hum Mutat; 2003 Sep; 22(3):183-98. PubMed ID: 12938083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of PTEN, a lipid phosphatase upstream effector of protein kinase B, in epithelial thyroid carcinogenesis.
    Eng C
    Ann N Y Acad Sci; 2002 Jun; 968():213-21. PubMed ID: 12119278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
    Marsh DJ; Coulon V; Lunetta KL; Rocca-Serra P; Dahia PL; Zheng Z; Liaw D; Caron S; Duboué B; Lin AY; Richardson AL; Bonnetblanc JM; Bressieux JM; Cabarrot-Moreau A; Chompret A; Demange L; Eeles RA; Yahanda AM; Fearon ER; Fricker JP; Gorlin RJ; Hodgson SV; Huson S; Lacombe D; Eng C
    Hum Mol Genet; 1998 Mar; 7(3):507-15. PubMed ID: 9467011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.
    Figer A; Kaplan A; Frydman M; Lev D; Paswell J; Papa MZ; Goldman B; Friedman E
    Clin Genet; 2002 Oct; 62(4):298-302. PubMed ID: 12372056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers.
    De Vivo I; Gertig DM; Nagase S; Hankinson SE; O'Brien R; Speizer FE; Parsons R; Hunter DJ
    J Med Genet; 2000 May; 37(5):336-41. PubMed ID: 10807691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome.
    Kim DK; Myung SJ; Yang SK; Hong SS; Kim KJ; Byeon JS; Lee GH; Kim JH; Min YI; Lee SM; Jeong JY; Song K; Jung SA
    Dis Colon Rectum; 2005 Sep; 48(9):1714-22. PubMed ID: 16007494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases.
    Hendriks YM; Verhallen JT; van der Smagt JJ; Kant SG; Hilhorst Y; Hoefsloot L; Hansson KB; van der Straaten PJ; Boutkan H; Breuning MH; Vasen HF; Bröcker-Vriends AH
    Fam Cancer; 2003; 2(2):79-85. PubMed ID: 14574156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.
    Sarquis MS; Agrawal S; Shen L; Pilarski R; Zhou XP; Eng C
    Am J Hum Genet; 2006 Jul; 79(1):23-30. PubMed ID: 16773562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
    Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
    Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
    Kurose K; Zhou XP; Araki T; Eng C
    Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome.
    Chen HJ; Romigh T; Sesock K; Eng C
    Hum Mutat; 2017 Oct; 38(10):1372-1377. PubMed ID: 28677221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN c.511C>T nonsense mutation in a BRRS family disrupts a potential exonic splicing enhancer and causes exon skipping.
    Suphapeetiporn K; Kongkam P; Tantivatana J; Sinthuwiwat T; Tongkobpetch S; Shotelersuk V
    Jpn J Clin Oncol; 2006 Dec; 36(12):814-21. PubMed ID: 17043057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
    Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
    Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults.
    Zhou XP; Marsh DJ; Morrison CD; Chaudhury AR; Maxwell M; Reifenberger G; Eng C
    Am J Hum Genet; 2003 Nov; 73(5):1191-8. PubMed ID: 14566704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.